Exp Hematol. 2008 Jun;36(6):733-41.

Immunosuppression by mesenchymal stromal cells: from culture to clinic.

Source

Solid Organ Transplant Team, Mater Medical Research Institute, University of Queensland, Brisbane, Australia.

Abstract

Extensive in vitro studies have shown that multipotent mesenchymal stromal cells (MSC) can exert profound immunosuppressive effects via modulation of both cellular and innate immune pathways. Their ability to be readily isolated from a number of tissues and expanded ex vivo makes them attractive candidates for systemic immunosuppressive therapy. In this article, we will review recent experimental data on the mechanisms by which MSC inhibit the alloproliferative response and the clinical relevance for their potential use in hematopoietic stem cell transplantation, solid organ transplantation, and treatment of autoimmune diseases. While in vitro data consistently demonstrate the immunosuppressive capability of MSC, current studies in animals and humans suggest that MSC are less effective in producing systemic immunosuppression. Further mechanistic studies and randomized controlled trials using standardized cell populations are needed to define the optimal conditions for the use of MSC as immunotherapy.

PMID:: 18474304; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

MeSH Terms

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Review [Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases?]. [Rev Med Interne. 2009]
Review [Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases?].
Larghero J, Vija L, Lecourt S, Michel L, Verrecchia F, Farge D. Rev Med Interne. 2009 Mar; 30(3):287-99. Epub 2008 Oct 17.
Review [Therapeutic application of mesenchymal stromal cells in autoimmune disease: rationale and initial clinical experience]. [Z Rheumatol. 2009]
Review [Therapeutic application of mesenchymal stromal cells in autoimmune disease: rationale and initial clinical experience].
Keysser G, Müller L, Schendel M, Schmoll HJ. Z Rheumatol. 2009 May; 68(3):220, 222-7.
No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. [Haematologica. 2007]
No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients.
Sundin M, Ringdén O, Sundberg B, Nava S, Götherström C, Le Blanc K. Haematologica. 2007 Sep; 92(9):1208-15. Epub 2007 Aug 1.
Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. [Haematologica. 2005]
Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.
Maccario R, Podestà M, Moretta A, Cometa A, Comoli P, Montagna D, Daudt L, Ibatici A, Piaggio G, Pozzi S, et al. Haematologica. 2005 Apr; 90(4):516-25.
Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation. [Immunol Invest. 2008]
Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
Tian Y, Deng YB, Huang YJ, Wang Y. Immunol Invest. 2008; 37(1):29-42.

See reviews... See all...

Cited by 18 PubMed Central articles

Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease-A Phase II Study. [Stem Cells Int. 2012]
Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease-A Phase II Study.
Kuzmina LA, Petinati NA, Parovichnikova EN, Lubimova LS, Gribanova EO, Gaponova TV, Shipounova IN, Zhironkina OA, Bigildeev AE, Svinareva DA, et al. Stem Cells Int. 2012; 2012:968213. Epub 2011 Dec 25.
Genetic and cellular aspects of the establishment of histocompatible stem cells: information gained from an animal model. [BMC Proc. 2011]
Genetic and cellular aspects of the establishment of histocompatible stem cells: information gained from an animal model.
Lim JM, Gong SP. BMC Proc. 2011 Jun 3; 5 Suppl 4:S31. Epub 2011 Jun 3.
Adipose-derived stromal cells: Their identity and uses in clinical trials, an update. [World J Stem Cells. 2011]
Adipose-derived stromal cells: Their identity and uses in clinical trials, an update.
Casteilla L, Planat-Benard V, Laharrague P, Cousin B. World J Stem Cells. 2011 Apr 26; 3(4):25-33.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Immunosuppression by mesenchymal stromal cells: from culture to clinic.
Immunosuppression by mesenchymal stromal cells: from culture to clinic.
Exp Hematol. 2008 Jun ;36(6):733-41.

PubMed
Aging of signal transduction pathways, and pathology.
Aging of signal transduction pathways, and pathology.
Exp Cell Res. 2008 Jun 10 ;314(9):1951-61. Epub 2008 Apr 7 .

PubMed
Astaxanthin: a novel potential treatment for oxidative stress and inflammation i...
Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease.
Am J Cardiol. 2008 May 22 ;101(10A):58D-68D.

PubMed
Advanced glycation end-product-inhibited cell proliferation and protein expressi...
Advanced glycation end-product-inhibited cell proliferation and protein expression of beta-catenin and cyclin D1 are dependent on glycogen synthase kinase 3beta in LLC-PK1 cells.
Arch Biochem Biophys. 2008 Sep 1 ;477(1):27-32. Epub 2008 Apr 29 .

PubMed
The genetics of psychotic bipolar disorder.
The genetics of psychotic bipolar disorder.
Curr Psychiatry Rep. 2008 Apr ;10(2):178-89.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: